India, Aug. 4 -- What are the major plans in store for the Indian biotech and pharma market at Anton Paar in 2026?

As analytical requirements become more sophisticated, our focus is on strengthening access to world-class analytical, testing and research technologies that support the complete product lifecycle from research and formulation development to quality control and manufacturing.

Anton Paar is continuously strengthening its analytical, testing and research portfolio to address the evolving needs of the biotechnology and pharmaceutical industries. As part of this strategy, we have revamped our product portfolio and introduced new analytical product lines across particle characterisation, rheology, density and concentration measur...